Gene therapy for muscular dystrophy – a review ofpromising progress

Author： Gregorevic Paul Chamberlain Jeffrey S

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.3, Iss.5, 2003-08, pp. : 803-814

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

AAV-directed muscular dystrophy gene therapy

By Tang Ying Cummins James Huard Johnny Wang Bing

Expert Opinion on Biological Therapy, Vol. 10, Iss. 3, 2010-03 ,pp. : 395-408

Informa Healthcare

Access to resources Recommend Favorite

Stem cell therapy for muscular dystrophy

By Sohn Regina Lee Gussoni Emanuela

Expert Opinion on Biological Therapy, Vol. 4, Iss. 1, 2004-01 ,pp. : 1-9

Informa Healthcare

Access to resources Recommend Favorite

Potential of oligonucleotide-mediated exon-skipping therapy for Duchenne muscular dystrophy

By Yokota Toshifumi Pistilli Emidio Duddy William Nagaraju Kanneboyina

Expert Opinion on Biological Therapy, Vol. 7, Iss. 6, 2007-06 ,pp. : 831-842

Informa Healthcare

Access to resources Recommend Favorite

Developing Effective Therapy for Duchenne Muscular Dystrophy (DMD): Challenges and Promises

Current Chemical Biology, Vol. 8, Iss. 3, 2014-01 ,pp. : 117-131

Bentham Science Publishers

Access to resources Recommend Favorite

How Does a g993t Mutation in the Emerin Gene Cause Emery–Dreifuss Muscular Dystrophy?

By Holt I. Clements L. Manilal S. Morris G.E.

Biochemical and Biophysical Research Communications, Vol. 287, Iss. 5, 2001-10 ,pp. : 1129-1133

Elsevier

Access to resources Recommend Favorite